You are here

RIPT of Ibuprofen Topical Gel

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Carlstadt, New Jersey, 07652 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Pain
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

Healthy male or female subjects 18 years of age or older, female subjects of childbearing
potential and males are using an acceptable form of birth control, subjects are free of any
systemic or dermatologic disorder

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

Have any visible skin disease at the application site, not willing to stop use of systemic
or topical analgesics, corticosteroids, or antihistamines, not willing to stop use of
sunscreens, creams, or similar products on the back during the study

NCT01787448
Pfizer
Completed
RIPT of Ibuprofen Topical Gel

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Sickle Cell Anemia, Sickle Cell Disease, Sickle Cell Disorders, Pain Crisis, Vaso-occlusive Crisis
NCT02433158
All Genders
6+
Years
Multiple Sites
Osteoarthritis, Cancer Pain, Recurrent Low Back Pain
NCT03031938
All Genders
0+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now